Bullish vs. Bearish (1 opinions)
Social Sentiment 0.00
AGRX Forecast and Technical Stock Analysis
Sell candidate since 2019-09-20 PDF
Agile Therapeutics fell by -1.69% in the last day ( Friday, 20th Sep 2019 ) from $1.18 to $1.16 and has now fallen 7 days in a row. During the day the stock fluctuated 4.42% from a day low at $1.13 to a day high of $1.18. The price has fallen in 7 of the last 10 days and is down by -15.33% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -575 219 shares and in total 797 895 shares bought and sold for approximately $925 558.00.
- 30 day high of the AGRX stock price was $1.59 and low was $1.03.
- 90 day high was $1.64 and low was $0.95.
- 52 week high for Agile Therapeutics - $1.70 and low - $0.32.
Agile Therapeutics lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -13.66% during the next 3 months and, with 90% probability hold a price between $0.75 and $1.28 at the end of this period.
There are few to none technical positive signals at the moment. Agile Therapeutics holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $1.32 and $1.18. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday September 12, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 54 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Agile Therapeutics finds support from accumulated volume at $1.12.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.05 between high and low, or 4.42%. For the last week the stock has had a daily average volatility of 7.37%.
Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.
7.37 %Average volatility
Very Low Low Medium High Very High
Agile Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate.
|AGRX $1.16 ($-0.02 -1.69%)|
AGRX is down $0.02 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for AGRX based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the AGRX analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!